Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Decompensated Liver Cirrhosis
NCT04932577Phase 3Recruiting
- Sponsor
- Aarhus University
- Start
- Jul 2021
- Primary completion
- May 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Liver cirrhosis (LC) comparing Faecal microbiota transplantation with Placebo (2 arms). Primary endpoint: Time to death or new episode of acute decompensation requiring intervention at 1 year. Started Jul 2021; status: recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT04932577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932577.